XR651, a novel naphthacene-5,12-dione

Journal of Antibiotics

Volumn 50, Issue 2, 1997, Pages 169-171

  Bahl, S ^a   Martin, S ^a   Rawlins, P ^a   Sadeghi, R ^a   Smith, P M ^a   Steel, J ^a   Shanu Wilson, P ^a   Wood, K A ^a   Wrigley, S K ^a  

^a Cantab Pharmaceuticals Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; NAPHTHACENE DERIVATIVE; UNCLASSIFIED DRUG; XR 651;

ACTINOBACTERIA; ARTICLE; CANCER CELL CULTURE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG ISOLATION; DRUG STRUCTURE; FERMENTATION; HUMAN; HUMAN CELL; INFRARED SPECTROMETRY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET SPECTROSCOPY;

EID: 0030888337     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.50.169     Document Type: Article

References (13)